AbbVie Inc.
Anti-huLRRC15 antibody drug conjugates and methods for their use
Last updated:
Abstract:
The present disclosure provides antibodies, antibody binding fragments, and antibody drug conjugates that bind human LRRC15, their methods of making, and their uses to treat patients having cancer.
Status:
Grant
Type:
Utility
Filling date:
13 Dec 2018
Issue date:
29 Jun 2021